MMP9 Inhibition Rescues the Erythroid Defect in RPS14-Deficient Del(5q) MDS Models
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-117508
Abstract: The del(5q) myelodysplastic syndrome (MDS) is a unique subtype of MDS characterized by an interstitial deletion of the long arm of chromosome 5 with macrocytic anemia, normal to increased platelet count, and hypoloblated megakaryocytes. Although… read more here.
Keywords: mds; treatment; rps14 deficient; del mds ... See more keywords